CVS Health posts strong revenue growth, takes charge for opioid deal

CVS Health Inc. booked a third-quarter loss of more than $3 billion after setting aside money for a potential opioid litigation deal, but still beat expectations and raised its 2022 forecast, Spectrum News NY1 reports. CVS Health reported sales growth in the quarter from all three of its main businesses as total revenue climbed 10% to $81.2 billion.